ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625492 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625492; 2) Community: the network communities that were significantly associated with the response to NSC 625492; 3) Molecule: the relationships between components within communities and NSC 625492; 4) MDR: the compounds that were significantly associated with the NSC 625492.

NSC Compound Enrichment Correlation
NSC 688228 Null 0.0321614375606959 0.27234316
NSC 6926 Null 0.0321614375606959 0.29340383
NSC 693248 Null 0.0321614375606959 0.32186495
NSC 718781 Erlotinib hydrochloride 0.0321614375606959 -0.25518623
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0321614375606959 0.21543196
NSC 722996 2-(4-chloro-benzyl)-1H-naphth[2,3-d]imidazole 0.0321614375606959 0.0053481215
NSC 726217 Combretastatin A4-analogue 0.0321614375606959 0.25218026
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.0321614375606959 0.059618531
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0321614375606959 -0.07774605
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0321614375606959 0.1194464
Total:91  Current:63    [First] [Prev] [Next] [Last]